纳米能源研究(英文)(Nano Research Energy)(OA期刊)(2025年12月31日之前不收费) 维普目次
- 国级普刊
- 主管单位:
教育部
- 主办单位:
清华大学
- 国际刊号:
2791-0091;EISSN 2790-8119
- 国内刊号:
10-1944/O6
- 学科分类:
- 字数:
4000-34000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-季刊
- 特殊属性:
外文期刊
- 电话:
010-83470497;15811166875(官网电话)
- 邮箱:
NanoResearchEnergy@tup.tsinghua.edu.cn(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
维普目次
- 级别:
国级普刊
期刊简介
《纳米能源研究(英文)(Nano Research Energy)(OA期刊)(2025年12月31日之前不收费)》期刊已被查看: 次
更新频次
单位占比
一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、刊内网址:(202402期)
https://www.sciopen.com/journal/2790-8119
https://mc03.manuscriptcentral.com/nre(投稿系统)
3、清华大学出版社期刊中心官网:
https://www.tsinghuajournals.com/cn/journal?id=1
4、官网邮箱:NanoResearchEnergy@tup.tsinghua.edu.cn
(更多编辑邮箱请查看期刊官网信息)
5、官网电话:010-83470497;15811166875
6、出刊日期:季刊,逢季末月出版。
7、官网信息:2025年12月31日之前免收APC费用。
2024年5月14日星期二
Nano Research Energy期刊介绍
【微信公众号信息】
Nano Research Energy(e-ISSN:2790-8119) 作为Nano Research姊妹刊,是清华大学出版社2022年6月创办的全英文开放获取期刊,由曲良体教授(清华大学)和支春义教授(香港城市大学)担任主编,入选了2022年度中国科技期刊卓越行动计划——高起点新刊项目,2025年之前免收APC费用
Nano Research Energy的办刊宗旨是通过出版和传播具有持久价值、卓越见地的研究成果,为纳米材料和纳米科技的发展服务。办刊目标是集聚全世界相关领域最权威的顾问、最敬业的编辑和最优秀的作者,努力建设成为能源领域最具影响力的学术期刊之一。除了发表原创的研究文章外,Nano Research Energy还将发表来自相关领域各方面的研究快报、综述、新闻、专家观点、研究亮点及评论。
能源低碳转型和高质量发展是当前世界面临的重大机遇与挑战,迫切需要深入推进能源生产和消费革命,构建清洁低碳、安全高效能源体系的重要支撑技术。Nano Research Energy作为一本国际化的多学科交叉期刊,聚焦纳米材料和纳米科学技术在新型能源相关领域的前沿研究与应用,包括但不限于电催化和光催化、燃料电池、新型电池技术、先进储能装置、超级电容器、生物能和生物燃料、碳捕集和储存技术、氢能、太阳能、风能、地热能、核能、水能、能源经济、能源安全等主题,对标国际顶级能源期刊,致力于发表高水平的原创性研究和综述类论文,助力“碳达峰、碳中和”目标的实现。
Nano Research Energy 是Nano Research姊妹刊,(ISSN: 2791-0091; e-ISSN: 2790-8119; 官网: https://www.sciopen.com/journal/2790-8119)于2022年6月创刊,由清华大学曲良体教授和香港城市大学支春义教授共同担任主编。Nano Research Energy是一本国际化的多学科交叉,全英文开放获取期刊,聚焦纳米材料和纳米科学技术在新型能源相关领域的前沿研究与应用,对标国际顶级能源期刊,致力于发表高水平的原创性研究和综述类论文,已入选2022年度中国科技期刊卓越行动计划——高起点新刊项目。2025年之前免收APC费用,欢迎各位老师踊跃投稿。
投稿请联系:NanoResearchEnergy@tup.tsinghua.edu.cn
投稿指南Guide for Authors
【官网信息】
1. BEFORE YOU BEGIN
Ethics in publishing
Please see our information on Ethics in Publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement in the submitted manuscript even if there are no interests to declare. Author signatures are not required.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. When coding terminology is used, we recommend to avoid offensive or exclusionary terms such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and (self-) explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright and APC charge
Upon acceptance of an article, authors will be asked to complete an 'Open Access Licence Agreement'. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Open Access Licence Agreement' form or a link to the online version of this agreement. Please note that the Article Processing Charge (APC) of this journal is waived by the end of 2023 or for invited authors.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, it is recommended to state this.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service by contacting the journal Editorial Office directly at NanoResearchEnergy@tup.tsinghua.edu.cn
2. SUBMISSION
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
……
更多详情:
https://www.sciopen.com/journal/join_journal/for_author?id=1500711144522428418&issn=2791-0091
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《纳米能源研究(英文)(Nano Research Energy)(OA期刊)(2025年12月31日之前不收费)》同类自科综合期刊
-
自然辩证法通讯(不收版面费审稿费)
C刊,北核,科核,AMI核心,武A-
CN中文-月刊影响因子1.052
-
科学技术与工程
北核,科核,武A-,CACJ-权威
CN中文-旬刊影响因子1.543
-
中国高校科技(原:中国高校科技与产业化)
AMI扩,武B+
CN中文-月刊影响因子1.63
-
自然辩证法研究
C刊,北核,科核,AMI核心,武A
CN中文-月刊影响因子1.066
-
中国科学基金(不收版面费)
北核,C扩,CSCD,科核,AMI扩,武B+
CN中文-双月刊影响因子2.712
-
轻工学报(原:郑州轻工业学院学报(自然科学版))(不收版面费审稿费)
北核,武B+,CACJ-入库
CN中文-双月刊影响因子1.025
-
中国科技论坛
C刊,北核,科核,武A,AMI扩
CN中文-月刊影响因子2.895
-
实验技术与管理
北核,科核,武A+
CN中文-月刊影响因子1.849
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。